Investment ThemesDetailed Quotes
Weight Loss Drugs Watchlist

GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.

  • 1464.463
  • +9.105+0.63%
Trading Jan 22 12:56 ET
1471.889High1453.292Low
Constituent Stocks: 7Top Rising: VKTX+2.86%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade

Comments

    While many are just looking at Trump's economy stocks these few days, some good news about $Novo-Nordisk A/S (NVO.US)$ diabetes drugs' additional benefits to preventing Alzheimer's desease, heart attack, seizure, stroke and more.  Unbelievable benefits for Ozembic aren't really that unexpected, considered many other drug companies are also focusing on researching & making similar drugs.
    $NVIDIA (NVDA.US)$ $Bitcoin (BTC.CC)$
    Good morning, team! Let’s dive into today’s market insights and highlight some stocks worth watching for potential options plays.
    Market Overview:
    The market is experiencing notable movements, with key players in the tech and financial sectors showing significant activity. It’s essential to stay informed and adapt strategies accordingly.
    Stocks to Watch:
    1. Tesla (TSLA):
    • Current Price: $424.07
    • Strategy: If TSLA breaks above the $430 resistance level, consider $440 call options expiring...
    1
    $Pfizer (PFE.US)$
    Full year earnings release on 04 Feb 2025. Waiting for good results
    $Pfizer (PFE.US)$
    Takeda-backed Ascentage Pharma Group (AAPG) (OTCPK:ASPHF), which is developing treatments for blood cancer, has set terms for a $170M U.S. initial public offering.
    In an SEC filing, Ascentage (AAPG) said it plans to offer 7.3M American Depositary Shares, representing 29.3M ordinary shares. While the company didn't disclose a price range, it indicated in its filing fee schedule it was looking to raise around $170M.
    The company hopes to list its shares on Nasdaq under the symbol A...
Read more